AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meyerand, M. E.
Right arrow Articles by Dunn, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meyerand, M. E.
Right arrow Articles by Dunn, J. F.

ARTICLE

Classification of Biopsy-Confirmed Brain Tumors Using Single-Voxel MR Spectroscopy

M. Elizabeth Meyerand,a, J. Marc Pipasa, Alex Mamouriana, Tor D. Tostesona and Jeffery F. Dunna

a From the Departments of Diagnostic Radiology (M.E.M., A.M., J.F.D.), Community and Family Medicine (T.D.T.), and Hematology and Oncology (J.M.P.), Biomedical NMR Research Lab, Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Hanover, NH.

BACKGROUND AND PURPOSE: Our purpose was to develop a classification scheme and method of presentation of in vivo single-voxel proton spectroscopic data from astrocytomas that most closely match the classification scheme determined from biopsy specimens. Since in vivo proton spectroscopy is noninvasive, it may be an attractive alternative to intracranial biopsy.

METHODS: Single-voxel spectra were acquired using the point-resolved spectroscopic pulse sequence as part of the Probe spectroscopy package on a G.E. 1.5-T Signa scanner. Subjects consisted of 27 patients with biopsy-confirmed brain tumors (13 with glioblastoma multiforme, six with anaplastic astrocytoma, and eight with low-grade astrocytoma). The patients were divided into groups based on the histologic subtype of their tumor for different treatment protocols.

RESULTS: Metabolic peak areas were normalized for each metabolite (choline, creatine, N-acetylaspartate, lactate) to the area of the unsuppressed water peak and to the area of the creatine peak. Kruskal-Wallis nonparametric analysis of variance (ANOVA) tests showed statistically significant differences among the tumor groups for all the area ratios. The lactate/water ratio could be used to distinguished all three tumor groups, whereas the choline/water ratio distinguished low-grade astrocytomas from the two high-grade groups. Both the choline and lactate ratios could be used to separate the high-grade from the low-grade tumors.

CONCLUSION: Specific relative metabolic peak area ratios acquired from regions of contrast-enhancing brain tumor can be used to classify astrocytomas as to histopathologic grade.




This article has been cited by other articles:


Home page
RadiologyHome page
J. F. Faria, S. M. Goldman, J. Szejnfeld, H. Melo, C. Kater, P. Kenney, M. P. Huayllas, G. Demarchi, V. V. Francisco, C. Andreoni, et al.
Adrenal Masses: Characterization with in Vivo Proton MR Spectroscopy Initial Experience
Radiology, December 1, 2007; 245(3): 788 - 797.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
R. N. Al-Okaili, J. Krejza, J. H. Woo, R. L. Wolf, D. M. O'Rourke, K. D. Judy, H. Poptani, and E. R. Melhem
Intraaxial Brain Masses: MR Imaging-based Diagnostic Strategy--Initial Experience
Radiology, May 1, 2007; 243(2): 539 - 550.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
E. Andre, M. Xu, D. Yang, J.K. Siow, T.T. Yeo, Y. Xu, and C.C.T. Lim
MR Spectroscopy in Sinus Mucocele: N-Acetyl Mimics of Brain N-Acetylaspartate
AJNR Am. J. Neuroradiol., November 1, 2006; 27(10): 2210 - 2213.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
N. A. Butowski, P. K. Sneed, and S. M. Chang
Diagnosis and Treatment of Recurrent High-Grade Astrocytoma
J. Clin. Oncol., March 10, 2006; 24(8): 1273 - 1280.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
K. Vuori, L. Kankaanranta, A.-M. Hakkinen, E. Gaily, L. Valanne, M.-L. Granstrom, H. Joensuu, G. Blomstedt, A. Paetau, and N. Lundbom
Low-Grade Gliomas and Focal Cortical Developmental Malformations: Differentiation with Proton MR Spectroscopy
Radiology, March 1, 2004; 230(3): 703 - 708.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M. Law, S. Yang, H. Wang, J. S. Babb, G. Johnson, S. Cha, E. A. Knopp, and D. Zagzag
Glioma Grading: Sensitivity, Specificity, and Predictive Values of Perfusion MR Imaging and Proton MR Spectroscopic Imaging Compared with Conventional MR Imaging
AJNR Am. J. Neuroradiol., November 1, 2003; 24(10): 1989 - 1998.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
N. Bulakbasi, M. Kocaoglu, F. Ors, C. Tayfun, and T. Ucoz
Combination of Single-Voxel Proton MR Spectroscopy and Apparent Diffusion Coefficient Calculation in the Evaluation of Common Brain Tumors
AJNR Am. J. Neuroradiol., February 1, 2003; 24(2): 225 - 233.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
C. Majos, J. Alonso, C. Aguilera, M. Serrallonga, J. J. Acebes, C. Arus, and J. Gili
Adult Primitive Neuroectodermal Tumor: Proton MR Spectroscopic Findings with Possible Application for Differential Diagnosis
Radiology, November 1, 2002; 225(2): 556 - 566.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Mardor, O. Kaplan, M. Sterin, J. Ruiz-Cabello, E. Ash, Y. Roth, I. Ringel, and J. S. Cohen
Noninvasive Real-Time Monitoring of Intracellular Cancer Cell Metabolism and Response to Lonidamine Treatment Using Diffusion Weighted Proton Magnetic Resonance Spectroscopy
Cancer Res., September 1, 2000; 60(18): 5179 - 5186.
[Abstract] [Full Text]